UNSPSC 51284028: Doxycycline hydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O8.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4182Z6T2ET. European Medicines Agency schedules doxycycline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01831MIG. Most nations, for tariff and trade purposes, schedule doxycycline hydrochloride under HS 29413000 and SITC 54133. As of Q4 2014, DOXYCYCLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Doxycycline hydrochloride bears US NLM identifiers UMLS ID C0771947 and NCI Concept Code C29010. SMILES: C[C@H]1C2CCCC(C2C(=O)C3=C([C@]4([C@@H]([C@H]([C@H]13)O)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O.CL.

UNSPSC 51284028 Doxycycline hydrochloride is a Commodity code that maps to pharmaceutical products, though the recent opportunities show state and local governments procuring a broader range of pharmaceutical goods, medical supplies, and pharmacy services rather than the specific active pharmaceutical ingredient named in the code. State and local issuing bodies under this code span health departments, counties, cities, fire departments, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The work being solicited includes direct procurement of generic pharmaceuticals and over-the-counter products through established wholesaler networks, emergency medical supplies for first-responder use, and pharmacy benefit program infrastructure supporting direct-to-manufacturer prescription fulfillment and cost management.

Recent activity shows geographic spread across Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023; the City of Tampa's IFB 26P00145, posted March 25, 2026, soliciting 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with a $700,000 estimated contract amount and a March 13, 2026 response date, designated as a sheltered market opportunity with a 5 percent bid discount for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802, issued January 20, 2026, to establish multi-vendor contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with responses due March 26, 2026 and weighted evaluation emphasizing price competitiveness at 75 percent. The Texas Health and Human Services Commission issued an exploratory RFI on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels.